[14] Extranodal plasmacytoma in a patient with multiple myeloma carries a poor prognosis and treatment, which includes chemotherapy or autologous hematopoietic cell transplantation, is directed ...

Treatment for multiple myeloma is important for the cancer's overall prognosis. Untreated, multiple myeloma can cause kidney damage or failure, bone fractures, cardiac arrest, or coma. The ...

Here are the diagnostic steps you might go through if a healthcare provider suspects you could have multiple myeloma: ...

Multiple myeloma causes changes in the blood cells that may lead to physical signs and symptoms. When you see your healthcare provider, they will probably ask about your symptoms and when they began.

We have previously demonstrated that interleukin-17A (IL-17) producing T helper 17 cells are significantly elevated in blood and bone marrow (BM) in multiple myeloma (MM) and IL-17A promotes MM ...

In 1998, the five-year survival rate for multiple myeloma was 34.6%. That means that approximately 35 of 100 people with the disease were alive five years after their diagnosis. By the early 2000s ...

The presence of t(4;14) and 17p13 deletion maintains a poor prognosis value in elderly patients with multiple myeloma.

Symptoms Symptoms of multiple myeloma can vary but often include ... such as monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, and amyloidosis. These conditions may require ...

A 59-year-old woman presented to the emergency department with a left rib fracture and was diagnosed with IgA multiple ... myeloma, even at the stage of terminal illness with extramedullary ...

These tests look for how much m-protein is in your blood, and what kind of m-protein you have. People with MGUS do not have symptoms or signs of multiple myeloma. Some people feel peripheral ...